ChemicalBook Product Catalog API Antineoplastic agents Regorafenib

1/1

Regorafenib

$ 1.00 /1KG

Min. Order1G
Purity98%
Cas No755037-03-7
Supply Ability100KG
Update time2019-07-06

career henan chemical co

7YR

China

Chemical Properties

Product Name	Regorafenib
CAS No	755037-03-7
EC-No
Min. Order	1G
Purity	98%
Supply Ability	100KG
Release date	2019/07/06

Company Profile Introduction

Recommended supplier

Regorafenib

$0.00/1g

BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.

VIP1Y

Regorafenib

$11.00/1Kg/Bag

Hebei Guanlang Biotechnology Co,.LTD

VIP4Y

Regorafenib (BAY 73-4506)

$1.00/1g

Apeloa production Co.,Limited

VIP1Y

Regorafenib

$5.00/1KG

Henan Fengda Chemical Co., Ltd

VIP1Y

Regorafenib

$0.00/1kg

Nanjing Fred Technology Co., Ltd

VIP1Y

Regorafenib

$0.00/1kg

Hebei Yanxi Chemical Co., Ltd.

VIP5Y

Regorafenib

$0.00/1kg

XuZhou Magic Biotechnology Co., Ltd.

Regorafenib

$0.00/1KG

Wuhan Senwayer Century Chemical Co.,Ltd

VIP2Y

Regorafenib

$10.00/1kg

Hebei Linwo New Material Technology Co., LTD

Regorafenib

$0.00/10g

Yangzhou Qinyuan Pharmatech Co.,ltd

VIP3Y

Send Inquriy

Product Name:	Regorafenib
Synonyms:	Regorafenib;BAY 73-4506;4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;BAY 73-4506(Regorafenib);4-[4-({[4-chioro-3-(trifluoroMethyl)phenyl]carbaMoyl}aMino)-3-fluorophenoxy]-pyridine-2-carboxylic acid MethylaMide;Regorafenib (BAY 73-4506);4-[4-[[[[4-Chloro-3-(trifluoroMethyl)phenyl]aMino]carbonyl]aMino]-3-fluorophenoxy]-N-Methyl-2-pyridinecarboxaMide;4-[4-[N'-(4-Chloro-3-trifluoroMethylphenyl)ureido]-3- fluorophenoxy]pyridine-2-carboxylic Acid MethylaMide
CAS:	755037-03-7
MF:	C21H15ClF4N4O3
MW:	482.8154128
EINECS:	1308068-626-2
Product Categories:	Amines;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Anti-cancer&immunity;Inhibitors
Mol File:	755037-03-7.mol

Uses	It inhibits PDGFR tyrosine kinase with IC50=83nM. It is useful for the treatment of inflammation and as an anti-proliferative agent.
Uses	BAY 73-4506 (Regorafenib) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf.
Uses	Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively
Definition	ChEBI: A pyridinecarboxamide obtained by condensation of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]pyridine-2-carboxylic acid with methylamine. Used for for the treatment of metastatic colorectal cancer in patients who have previ usly received chemotherapy, anti-EGFR or anti-VEGF therapy.

Regorafenib

Company Profile Introduction

You may like

Recommended supplier